Related references
Note: Only part of the references are listed.Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studies
Michael U. Callaghan et al.
BLOOD (2021)
Guidelines on the use of prophylactic factor replacement for children and adults with Haemophilia A and B
Rachel Rayment et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Emicizumab treatment and monitoring in a paediatric cohort: real-world data
Assaf A. Barg et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Initiation of emicizumab prophylaxis in an infant with haemophilia A and subdural haemorrhage
Kelly A. Bush et al.
HAEMOPHILIA (2020)
Mode of delivery in hemophilia: vaginal delivery and Cesarean section carry similar risks for intracranial hemorrhages and other major bleeds
Nadine G. Andersson et al.
HAEMATOLOGICA (2019)
Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study
Steven W. Pipe et al.
LANCET HAEMATOLOGY (2019)
A multicentre, open-label study of emicizumab given every 2 or 4 weeks in children with severe haemophilia A without inhibitors
Midori Shima et al.
HAEMOPHILIA (2019)
A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors
Guy Young et al.
BLOOD (2019)
Intracranial Hemorrhage in Children With Inherited Bleeding Disorders: A Single Center Study in China
Qareen Haque et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2019)
Intracranial haemorrhage in children with inherited bleeding disorders in the UK 2003-2015: A national cohort study
E. A. Chalmers et al.
HAEMOPHILIA (2018)
Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors
J. Mahlangu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Immunogenicity of Emicizumab in People with Hemophilia A (PwHA): Results from the HAVEN 1-4 Studies
Ido Paz-Priel et al.
BLOOD (2018)
Emicizumab Prophylaxis in Hemophilia A with Inhibitors
Johannes Oldenburg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The incidence, risk and functional outcomes of intracranial haemorrhage in children with inherited bleeding disorders at one haemophilia center
M. Bladen et al.
HAEMOPHILIA (2016)
When and how to start prophylaxis in boys with severe hemophilia without inhibitors: communication from the SSC of the ISTH
K. Fischer et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Factor VIII-Mimetic Function of Humanized Bispecific Antibody in Hemophilia A
Midori Shima et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Bleeding before prophylaxis in severe hemophilia: paradigm shift over two decades
Annelies Nijdam et al.
HAEMATOLOGICA (2015)
Complications associated with central and non-central venous catheters in a neonatal intensive care unit
K. Colacchio et al.
JOURNAL OF PERINATOLOGY (2012)
Intracranial haemorrhage in patients with congenital haemostatic defects
P. Mishra et al.
HAEMOPHILIA (2008)
Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia
Marilyn J. Manco-Johnson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Share Paper
